Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 25, Iss 3, Pp 163-169 (2014)
The Canadian Journal of Infectious Diseases & Medical Microbiology
The Canadian Journal of Infectious Diseases & Medical Microbiology
The quinolone class of antibiotics has become an integral component of the antimicrobial arsenal. However, the presence of plasmid-mediated quinolone resistance genes has been increasing in Enterobacteriaceae since the introduction of quinolones. Thi
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 23, Iss 2, Pp 59-64 (2012)
Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.A decision-analytic model
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 19 (2018)
Journal of the Renin-Angiotensin-Aldosterone System: JRAAS
Journal of the Renin-Angiotensin-Aldosterone System: JRAAS
Introduction: We measured the effects of azilsartan medoxomil co-administered with chlorthalidone 25 mg in stage 2 hypertension. Methods: Azilsartan medoxomil 40 or 80 mg plus chlorthalidone were compared with placebo plus chlorthalidone once daily i
Autor:
Eric M Yoshida, Morris Sherman, Vincent G Bain, Curtis L Cooper, Marc Deschênes, Paul J Marotta, Samuel S Lee, Mel Krajden, Helga Witt-Sullivan, Robert J Bailey, Christopher Usaty, Kevork Peltekian, null the Canadian Pegasys Study Group
Publikováno v:
Kevork M Peltekian
Canadian Journal of Gastroenterology, Vol 23, Iss 3, Pp 180-184 (2009)
ResearcherID
Canadian Journal of Gastroenterology, Vol 23, Iss 3, Pp 180-184 (2009)
ResearcherID
BACKGROUND: Pegylated interferon (pegIFN) and ribavirin combination therapy remains the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the wealth of studies in treatment-naive patients, the effectiveness of retreat
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 14, Iss 4, Pp 201-205 (2003)
OBJECTIVE: To assess the efficacy of nelfinavir mesylate (NFV) in combination with delavirdine mesylate(DLV) or efavirenz (EFV) and other antiretroviral agents following virological failure on other protease inhibitor (PI)-based regimens.DESIGN: Mult